Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateTimeSourceHeadlineSymbolCompany
12/06/200917:53Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/06/200911:05Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/06/200914:00Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/05/200913:00Business WireAllos Therapeutics Reports Updated Data from Pivotol Phase 2 PROPEL Study of Pralatrexate at 45th ASCO Annual MeetingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/05/200913:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/05/200913:00Business WireAllos Therapeutics Announces FDA Accepts Pralatrexate NDA for Filing and Grants the Application Priority Review StatusNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/05/200923:15Business WireAllos Therapeutics Announces Updated Data from Pivotol Phase 2 PROPEL Study of Pralatrexate to be Presented at ASCO 2009NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/05/200913:00Business WireAllos Therapeutics to Present at the Eighth Annual JMP Securities Research ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/05/200922:01Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/05/200921:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/05/200921:00Business WireAllos Therapeutics Reports First Quarter 2009 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/04/200913:31Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
28/04/200921:00Business WireAllos Therapeutics to Report First Quarter 2009 Results on May 5, 2009NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/04/200912:54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
19/04/200920:00Business WireAllos Therapeutics’ Pralatrexate Demonstrates Anticancer Activity in Multiple Cancer Cell LinesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
15/04/200913:00Business WireAllos Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2009NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/04/200921:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/04/200921:00Business WireAllos Therapeutics Announces Closing of Common Stock OfferingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/04/200921:14Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/04/200921:10Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
31/03/200914:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
31/03/200914:00Business WireAllos Therapeutics Announces Pricing of Common Stock OfferingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/03/200921:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/03/200912:00Business WireAllos Therapeutics to Present at the 4th Annual Citi Biotech DayNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/03/200912:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/03/200912:00Business WireAllos Therapeutics Submits New Drug Application for Pralatrexate for Patients with Relapsed or Refractory Peripheral T-cell L...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/03/200921:30Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/03/200912:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
24/03/200912:00Business WireAllos Therapeutics Appoints David M. Stout to Its Board of DirectorsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
20/03/200920:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Your Recent History

Delayed Upgrade Clock